Biotech

All Articles

Repare gives up 25% of workers as biotech standstills preclinical R&ampD

.Repare Rehab is actually laying off a quarter of its labor force as the oncology biotech downsize i...

J &amp J declare FDA confirmation of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually gotten one more step toward recognizing a profit on its own $6.5 ...

Gain's phase 1 win leads method to verify Parkinson's medication's worth

.Increase Therapies has actually established its own direct confirming the effectiveness of its own ...

Actinogen documents brand new phase 2 information to salvage clinical depression medication

.Actinogen Medical's chances-- and also supply price-- have rebounded slightly from previously this ...

Pfizer and Main add Ratio to multibillion-dollar formula

.Flagship Pioneering as well as Pfizer have actually incorporated Quotient into their 10-program rel...

Bayer markers $547M deal to press borders of noncoding RNA

.Bayer execs were keen to anxiety to Intense this summertime that the German pharma titan's hunger f...

UK unveils strategies to introduce 18 brand new medical trial hubs

.Surrounded by a yearslong professional trial decrease in the U.K., a new public-private alliance ha...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer cells immunology analysis unit

.Following the statement of a huge cutback shot in April as well as a primary restructuring initiati...

Neurocrine's KarXT opponent hits in stage 2-- but only at low dose

.Neurocrine Biosciences has accomplished its hoped-for profile in a phase 2 schizophrenia test, supp...

Vaderis' rare blood vessel problem medication lessens nosebleeds

.Vaderis Rehabs' target to build the very first medicine targeted specifically at a particular rare ...